Business · 21/06/2007Updated: 10/17/2026 · 1 min read
FDA Announces Availability of Revised Draft Guidance on Pharmacovigilance of Veterinary Medicinal Products
Summary
The FDA is seeking public comments on a revised draft guidance for the pharmaceutical industry on pharmacovigilance of veterinary medicinal products, which outlines the data elements for reporting adverse events.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →